Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Atopaxar (E5555), a reversible PAR-1 thrombin receptor antagonist, interferes with platelet signaling. Atopaxar has been investigated for the treatment of Coronary Artery Disease and Acute Coronary Syndrome.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
1 mg | 在庫あり | ¥ 15,500 | |||
5 mg | 在庫あり | ¥ 32,000 | |||
10 mg | 在庫あり | ¥ 58,500 | |||
25 mg | 在庫あり | ¥ 106,500 | |||
50 mg | 在庫あり | ¥ 156,500 | |||
100 mg | 在庫あり | ¥ 222,500 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 36,500 |
説明 | Atopaxar (E5555), a reversible PAR-1 thrombin receptor antagonist, interferes with platelet signaling. Atopaxar has been investigated for the treatment of Coronary Artery Disease and Acute Coronary Syndrome. |
別名 | E5555, ER-172594-00 |
分子量 | 527.63 |
分子式 | C29H38FN3O5 |
CAS No. | 751475-53-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 25 mg/mL (47.38 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Atopaxar 751475-53-3 GPCR/G Protein Protease-activated Receptor platelets receptor-1 signaling PAR-1 E5555 inhibit E-5555 Inhibitor receptor Protease Activated Receptor (PAR) protease-activated atherothrombotic thrombin E 5555 Thrombin receptors ER-172594-00 inhibitor